Поиск по репозиторию
Статья
Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
2021
Patients on anticoagulant treatment are constantly increasing, with an estimated prevalence in Italy of 2% of the total population. The recent spreadout of the COVID-19 pandemic requires a re-organization of Anticoagulation Clinics to prevent person-to-person viral diffusion and continue to offer the highest possible quality of assistance to patients. In this paper, based on the Italian Federation of Anticoagulation Clinics statements, we offer some advice aimed at improving patient care during COVID-19 pandemic, with particular regard to the lockdown and reopening periods. We give practical guidance regarding the following points: (1) re-thinking the AC organization, (2) managing patients on anticoagulants when they become infected by the virus, (3) managing anticoagulation surveillance in non-infected patients during the lockdown period, and (4) organizing the activities during the reopening phases. © 2020, The Author(s).
Цитирование
Похожие публикации
Версии
- 1. Version of Record от 2021-04-27
Метаданные
Название журнала
- Internal and Emergency Medicine
Том
- 15
Выпуск
- 5
Страницы
- 783-786
Ключевые слова
- anticoagulant agent; Betacoronavirus; complication; Coronavirus infection; human; Italy; outpatient department; pandemic; quarantine; risk factor; virus pneumonia; Ambulatory Care Facilities; Anticoagulants; Betacoronavirus; Coronavirus Infections; Humans; Italy; Pandemics; Pneumonia, Viral; Quarantine; Risk Factors
Издатель
- Springer
Тип документа
- journal article
Тип лицензии Creative Commons
- CC
Правовой статус документа
- Свободная лицензия
Источник
- scopus
